Recent advancement in stem cell treatment of coronary artery lesion of kawasaki disease
Abstract
Kawasaki Disease (KD) is an acute, self-limited systemic vasculitis that affects the middle and small arteries, especially the coronary arteries. The incidence of KD is currently on the rise, with about 15 to 25 percent of children without systemic treatment, eventually developing coronary artery damage, Becoming the most common cause of child-acquired heart disease in the developed countries. At present, stem cell therapy for Kawasaki Disease in mice model has made important progress. This article reviews stem cell treatment of coronary artery lesion of Kawasaki Disease.
Downloads
Copyright (c) 2020 Author
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Authors retain copyright (full ownership) to their content published in the Journal. We claim no intellectual property rights over the material provided by any User in this Journal. However, by setting pages to be viewed publicly (Open Access), the User agrees to allow others to view and download the relevant content. In addition, Open Access articles might be used by the Provider, or any other third party, for data mining purposes.
The Provider reserves the rights in its sole discretion to refuse or remove any content that is available via the Website.